Guardian Cost Of Revenue from 2010 to 2024

GCG Stock  CAD 42.50  0.50  1.19%   
Guardian Capital Cost Of Revenue yearly trend continues to be very stable with very little volatility. Cost Of Revenue is likely to grow to about 139.6 M this year. During the period from 2010 to 2024, Guardian Capital Cost Of Revenue quarterly data regression pattern had sample variance of 3035.7 T and median of  137,444,000. View All Fundamentals
 
Cost Of Revenue  
First Reported
2009-03-31
Previous Quarter
34.3 M
Current Value
63.1 M
Quarterly Volatility
23.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Guardian Capital financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Guardian Capital's main balance sheet or income statement drivers, such as Depreciation And Amortization of 14.7 M, Interest Expense of 8.7 M or Total Revenue of 165.9 M, as well as many indicators such as Price To Sales Ratio of 3.88, Dividend Yield of 0.0294 or PTB Ratio of 1.73. Guardian financial statements analysis is a perfect complement when working with Guardian Capital Valuation or Volatility modules.
  
This module can also supplement various Guardian Capital Technical models . Check out the analysis of Guardian Capital Correlation against competitors.

Pair Trading with Guardian Capital

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Guardian Capital position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guardian Capital will appreciate offsetting losses from the drop in the long position's value.

Moving against Guardian Stock

  0.63CMC Cielo Waste SolutionsPairCorr
  0.47EOG Eco Atlantic OilPairCorr
  0.44AEMC Alaska Energy MetalsPairCorr
The ability to find closely correlated positions to Guardian Capital could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Guardian Capital when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Guardian Capital - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Guardian Capital Group to buy it.
The correlation of Guardian Capital is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Guardian Capital moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Guardian Capital moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Guardian Capital can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Guardian Stock

Guardian Capital financial ratios help investors to determine whether Guardian Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Guardian with respect to the benefits of owning Guardian Capital security.